Literature DB >> 23397255

International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.

D Creely1, G Zambardi, A van Belkum, Wm M Dunne, M Peyret, J P Gayral, D Shortridge, C Shubert.   

Abstract

Preventing the dissemination of antimicrobial resistance depends on appropriate antibiotic stewardship and accurate antimicrobial susceptibility testing (AST). We report the international dissemination of Escherichia coli strains, showing discrepancies between reference methods when phenotypically tested for susceptibility to piperacillin/tazobactam (TZP). We demonstrate that these related strains are predisposed to problematic TZP AST interpretations.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23397255     DOI： 10.1007/s10096-013-1837-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  18 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.

Authors:  P Giakkoupi; L S Tzouvelekis; G L Daikos; V Miriagou; G Petrikkos; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains.

Authors:  Kenneth S Thomson; Jennifer Black; Ellen Smith Moland; Jay Reuben; Tim Wiles; William Brasso
Journal:  Int J Antimicrob Agents       Date:  2007-11-08       Impact factor: 5.283

4.  Semi-automated rep-PCR for rapid differentiation of major clonal groups of Escherichia coli meningitis strains.

Authors:  Stéphane Bonacorsi; Philippe Bidet; Farah Mahjoub; Patricia Mariani-Kurkdjian; Shadia Ait-Ifrane; Céline Courroux; Edouard Bingen
Journal:  Int J Med Microbiol       Date:  2009-05-17       Impact factor: 3.473

5.  Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used.

Authors:  V Prakash; J S Lewis; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

6.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.

Authors:  Kuei-Hsiang Hung; Ming-Cheng Wang; Ay-Huey Huang; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

8.  Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species.

Authors:  A C Fluit; A M Terlingen; L Andriessen; R Ikawaty; R van Mansfeld; J Top; J W Cohen Stuart; M A Leverstein-van Hall; C H E Boel
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

9.  Comparison of the accuracy of disk diffusion zone diameters obtained by manual zone measurements to that by automated zone measurements to determine antimicrobial susceptibility.

Authors:  Endang Sri Lestari; Juliëtte A Severin; P Margreet G Filius; Kuntaman Kuntaman; D Offra Duerink; Usman Hadi; Hendro Wahjono; Henri A Verbrugh
Journal:  J Microbiol Methods       Date:  2008-06-27       Impact factor: 2.363

10.  Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.

Authors:  L López-Cerero; E Picón; C Morillo; J R Hernández; F Docobo; J Pachón; J Rodríguez-Baño; A Pascual
Journal:  Clin Microbiol Infect       Date:  2009-07-15       Impact factor: 8.067
View more
  3 in total

1.  Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing.

Authors:  Carole Shubert; Jen Slaughter; David Creely; Alex van Belkum; Jean Pierre Gayral; William Michael Dunne; Gilles Zambardi; Dee Shortridge
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 2.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

3.  Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli.

Authors:  Lisa M Schechter; David P Creely; Cherilyn D Garner; Dee Shortridge; Hoan Nguyen; Lei Chen; Blake M Hanson; Erica Sodergren; George M Weinstock; W Michael Dunne; Alex van Belkum; Shana R Leopold
Journal:  MBio       Date:  2018-04-24       Impact factor: 7.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.